1.3 CME

The Rise of FGIDs in Pediatric Practice

Speaker: Dr. K.Dhanasekhar

Consultant Pediatric Gastroenterologist, Apollo Children's Hospitals, Chennai

Login to Start

Description

The panel discussion on "The Rise of FGIDs in Pediatric Practice" will delve into the increasing prevalence of Functional Gastrointestinal Disorders among children and its implications for healthcare providers. The discussion will feature experts who will explore the multifaceted nature of these disorders, including the latest diagnostic approaches, treatment modalities, and the role of diet and psychological interventions. The panel aims to provide a comprehensive understanding of FGIDs, addressing both clinical challenges and opportunities for improving patient outcomes. Attendees will gain insights into the evolving landscape of pediatric gastroenterology and the importance of a multidisciplinary approach in managing these complex conditions.

Summary Listen

  • The discussion centered on the increasing recognition of the gut microbiota as a central organ in the human body, with implications for overall health and development. The gut microbiota, a complex ecosystem of microorganisms, is present throughout the gastrointestinal tract, with the highest concentration in the colon, and plays a role from fetal development to adulthood.
  • Gut microbiota maturation is maximal in the first two years of life and is divided into developmental, transitional, and stable phases. Factors influencing this process include delivery method (vaginal vs. C-section), breastfeeding vs. formula feeding, introduction of solids, dietary fiber intake, and antibiotic exposure.
  • Functional gastrointestinal disorders (FGIDs) are increasing, possibly due to lifestyle changes, maternal stress, high carbohydrate intake, decreased fiber intake, and improper feeding practices. Early identification and management of FGIDs are crucial, considering the potential long-term implications, including behavioral changes, anxiety, and psychiatric problems.
  • Prebiotics, such as FOS and GOS, nourish beneficial bacteria in the gut and sustain the gut microbiota. A 9:1 ratio of GOS/FOS has shown clinical benefits in reducing FGID symptoms. Probiotics, particularly *L. reuteri* (DSM 17938), have demonstrated efficacy in managing colic, regurgitation, fuzziness, and hard stools.
  • The gut-brain axis highlights the connection between the gut microbiota and the nervous system, influencing growth, cognition, sleep, and anxiety. Maintaining a healthy gut microbiota is essential for overall physical and mental development. The overuse of antibiotics should be avoided, and dietary recommendations should promote a diverse and balanced gut microbiome.
  • Nutritional management strategies include dietary modifications, such as eliminating cow's milk protein if necessary, using appropriate formulas with prebiotics and probiotics, and avoiding early introduction of solids. Breastfeeding, proper feeding practices, and the incorporation of pre- and probiotics contribute to maintaining a balanced gut microbiota and managing FGIDs effectively.

Comments